Table 1 Ascertainment of pregnant women with depression from dispensing data, 2002-2005
From: Are women with major depression in pregnancy identifiable in population health data?
| Â | Pregnancy Risk Code | Dispenses | PBS cases | PBS, no HMDS | PBS and HMDS | ||||
|---|---|---|---|---|---|---|---|---|---|
| Â | Â | N | % | N | % | N | % | N | % |
Pharmaceutical Benefits Scheme | Â | 20879 | 100.0% | 4485 | 100.0% | 3586 | 80.0% | 899 | 20.0% |
Sertraline hydrochloride | C | 5536 | 26.5% | 1340 | 29.9% | 1082 | 30.2% | 258 | 28.7% |
Citalopram hydrobromide | C | 4784 | 22.9% | 1136 | 25.3% | 897 | 25.0% | 239 | 26.6% |
Paroxetine hydrochloride* | C/D | 3180 | 15.2% | 676 | 15.1% | 565 | 15.8% | 111 | 12.3% |
Venlafaxine hydrochloride | B2 | 3146 | 15.1% | 581 | 13.0% | 430 | 12.0% | 142 | 15.8% |
Fluoxetine hydrochloride | C | 1509 | 7.2% | 364 | 8.1% | 280 | 7.8% | 84 | 9.3% |
Escitalopram oxalate | C | 775 | 3.7% | 241 | 5.4% | 189 | 5.3% | 52 | 5.8% |
Mirtazapine | B3 | 510 | 2.4% | 140 | 3.1% | 85 | 2.4% | 55 | 6.1% |
Fluvoxamine maleate | C | 412 | 2.0% | 140 | 3.1% | 115 | 3.2% | 25 | 2.8% |
Amitriptyline hydrochlorine | C | 273 | 1.3% | 105 | 2.3% | 79 | 2.2% | 26 | 2.9% |
Dothiepin hydrochloride | C | 376 | 1.8% | 78 | 1.7% | 62 | 1.7% | 16 | 1.8% |
Moclobemide | B3 | 92 | 0.4% | 40 | 0.9% | 34 | 0.9% | 6 | 0.7% |
Doxepine hydrochloride | C | 137 | 0.7% | 32 | 0.7% | 20 | 0.6% | 12 | 1.3% |
Reboxetine mesilate | B1 | 89 | 0.4% | 24 | 0.5% | 16 | 0.4% | 8 | 0.9% |
Imipramine hydrochloride | C | 31 | 0.1% | 8 | 0.2% | 6 | 0.2% | <5 | 0.2% |
Mianserin hydrochloride | B2 | 9 | 0.0% | 6 | 0.1% | <5 | 0.1% | <5 | 0.2% |
Nefazodone hydrochloride | B3 | 14 | 0.1% | 5 | 0.1% | <5 | 0.1% | <5 | 0.1% |
Nortriptyline hydrochloride | C | 6 | 0.0% | <5 | 0.1% | <5 | 0.1% | 0 | 0.0% |